Maria Cristina Meriggiola (Maria C Meriggiola, Cristina Meriggiola)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Postmenopausal Women

Cervical Cancer Screening

Top Venues

Medicina (Kaunas, Lithuania)

Therapeutic advances in endocrinology and metabolism

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Cristina Meriggiola, Dimitrios G Goulis
Contraceptive counseling: Shared decision on contraceptive choices. Andrology (2024)
Christina Wang, Maria Cristina Meriggiola, Hermann M Behre, Stephanie T Page
Hormonal male contraception. Andrology (2024)
Alessandra Lami, Giulia Giacomelli, Jacopo Lenzi, Stefania Alvisi, Renato Seracchioli, Maria Cristina Meriggiola
The COVID-19 Pandemic Impact on the Psychophysical Health of Post-Menopausal Women: A Cross-Sectional Study. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Alessandra Lami, Giulia Giacomelli, Jacopo Lenzi, Stefania Alvisi, Renato Seracchioli, Maria Cristina Meriggiola
The COVID-19 Pandemic Impact on the Psychophysical Health of Post-Menopausal Women: A Cross-Sectional Study. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Alessandra Lami, Giulia Giacomelli, Jacopo Lenzi, Stefania Alvisi, Renato Seracchioli, Maria Cristina Meriggiola
The COVID-19 Pandemic Impact on the Psychophysical Health of Post-Menopausal Women: A Cross-Sectional Study. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Giulia Giacomelli, Maria Cristina Meriggiola
Bone health in transgender people: a narrative review. Therapeutic advances in endocrinology and metabolism 13 (2022)
Carlotta Cocchetti, Alessia Romani, Francesca Mazzoli, Jiska Ristori, Filippo Lagi, Maria Cristina Meriggiola, Giovanna Motta, Marina Pierdominici, Alessandro Bartoloni, Linda Vignozzi, Mario Maggi, Alessandra Daphne Fisher
Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study. Journal of clinical medicine 11 (10) (2022)
Silvia Giagio, Tiziano Innocenti, Stefano Salvioli, Alessandra Lami, Maria Cristina Meriggiola, Paolo Pillastrini, Giulia Gava
Completeness of exercise reporting among randomized controlled trials on pelvic floor muscle training for women with pelvic organ prolapse: A systematic review. Neurourology and urodynamics 40 (6) (2021)
Nina Tyutyusheva, Ilaria Mancini, Giampiero Igli Baroncelli, Sofia D'Elios, Diego Giampietro Peroni, Maria Cristina Meriggiola, Silvano Bertelloni
Complete Androgen Insensitivity Syndrome: From Bench to Bed. International journal of molecular sciences 22 (3) (2021)
Ilaria Mancini, Davide Tarditi, Giulia Gava, Stefania Alvisi, Luca Contu, Paolo Giovanni Morselli, Giulia Giacomelli, Alessandra Lami, Renato Seracchioli, Maria Cristina Meriggiola
Feasibility, Safety, and Satisfaction of Combined Hysterectomy with Bilateral Salpingo-Oophorectomy and Chest Surgery in Transgender and Gender Non-Conforming Individuals. International journal of environmental research and public health 18 (13) (2021)
Ilaria Mancini, Stefania Alvisi, Giulia Gava, Renato Seracchioli, Maria Cristina Meriggiola
Contraception across transgender. International journal of impotence research 33 (7) (2021)
Elisa Moro, Eugenia Degli Esposti, Giulia Borghese, Federica Manzara, Margherita Zanello, Diego Raimondo, Giulia Gava, Alessandro Arena, Paolo Casadio, Maria Cristina Meriggiola, Renato Seracchioli
The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature. Medicina (Kaunas, Lithuania) 55 (9) (2019)
Giulia Gava, Maria Cristina Meriggiola
Update on male hormonal contraception. Therapeutic advances in endocrinology and metabolism 10 (2019)
Stefania Alvisi, Giulia Gava, Isabella Orsili, Giulia Giacomelli, Maurizio Baldassarre, Renato Seracchioli, Maria Cristina Meriggiola
Vaginal Health in Menopausal Women. Medicina (Kaunas, Lithuania) 55 (10) (2019)
Giulia Gava, Ilaria Mancini, Silvia Cerpolini, Maurizio Baldassarre, Renato Seracchioli, Maria Cristina Meriggiola
Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration. Clinical endocrinology 89 (6) (2018)